IQVIA HOLDINGS ($IQV) posted quarterly earnings results on Tuesday, October 28th. The company reported earnings of $3.00 per share, missing estimates of $3.00 by $0.00. The company also reported revenue of $4,100,000,000, missing estimates of $4,116,594,612 by $-16,594,612.
You can see Quiver Quantitative's $IQV stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
IQVIA HOLDINGS Insider Trading Activity
IQVIA HOLDINGS insiders have traded $IQV stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $IQV stock by insiders over the last 6 months:
- ERIC SHERBET (See Remarks) sold 5,800 shares for an estimated $1,102,290
- KERIANN CHEROFSKY (See Remarks) sold 549 shares for an estimated $105,149
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
IQVIA HOLDINGS Hedge Fund Activity
We have seen 540 institutional investors add shares of IQVIA HOLDINGS stock to their portfolio, and 449 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARTISAN PARTNERS LIMITED PARTNERSHIP added 3,272,872 shares (+inf%) to their portfolio in Q2 2025, for an estimated $515,771,898
- FMR LLC added 1,976,482 shares (+212.5%) to their portfolio in Q2 2025, for an estimated $311,473,798
- MITSUBISHI UFJ ASSET MANAGEMENT CO., LTD. removed 1,602,225 shares (-83.1%) from their portfolio in Q2 2025, for an estimated $252,494,637
- PITCAIRN CO added 1,593,630 shares (+69560.5%) to their portfolio in Q2 2025, for an estimated $251,140,151
- MORGAN STANLEY removed 957,424 shares (-28.5%) from their portfolio in Q2 2025, for an estimated $150,880,448
- AQR CAPITAL MANAGEMENT LLC added 879,701 shares (+130.2%) to their portfolio in Q2 2025, for an estimated $138,632,080
- ALYESKA INVESTMENT GROUP, L.P. added 745,904 shares (+inf%) to their portfolio in Q2 2025, for an estimated $117,547,011
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
IQVIA HOLDINGS Congressional Stock Trading
Members of Congress have traded $IQV stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $IQV stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 05/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
IQVIA HOLDINGS Analyst Ratings
Wall Street analysts have issued reports on $IQV in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HSBC issued a "Buy" rating on 10/09/2025
- Evercore ISI Group issued a "Outperform" rating on 10/08/2025
- Jefferies issued a "Buy" rating on 09/09/2025
- Mizuho issued a "Outperform" rating on 07/25/2025
- UBS issued a "Buy" rating on 07/23/2025
- JP Morgan issued a "Overweight" rating on 05/19/2025
To track analyst ratings and price targets for IQVIA HOLDINGS, check out Quiver Quantitative's $IQV forecast page.
IQVIA HOLDINGS Price Targets
Multiple analysts have issued price targets for $IQV recently. We have seen 9 analysts offer price targets for $IQV in the last 6 months, with a median target of $225.0.
Here are some recent targets:
- Rajesh Kumar from HSBC set a target price of $235.0 on 10/09/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $240.0 on 10/08/2025
- Luke Sergott from Barclays set a target price of $200.0 on 10/02/2025
- David Windley from Jefferies set a target price of $225.0 on 09/09/2025
- Ann Hynes from Mizuho set a target price of $225.0 on 07/25/2025
- Eric Coldwell from Baird set a target price of $196.0 on 07/23/2025
- Jailendra Singh from Truist Securities set a target price of $235.0 on 07/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.